Clinical Trials Browser

Phase 3 × INDUSTRY × Advanced Non-small Cell Lung Cancer × Clear all

NCT06452277 2026-03-02

SOHO-02

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

NCT03856697 2019-02-27

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Phase 3 Unknown

Advanced Non-small Cell Lung Cancer